New Delhi, April 7 Biocon Ltd announced on Tuesday the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (a biosimilar to Prolia) and Aukelso (a biosimilar to Xgeva) are now available by prescription nationwide through...
New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...